These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9075462)

  • 1. Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients.
    Marangell LB; George MS; Callahan AM; Ketter TA; Pazzaglia PJ; L'Herrou TA; Leverich GS; Post RM
    Arch Gen Psychiatry; 1997 Mar; 54(3):214-22. PubMed ID: 9075462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The thyrotropin response to thyrotropin-releasing hormone as a predictor of response to treatment in depressed outpatients.
    Fava M; Rosenbaum JF; Birnbaum R; Kelly K; Otto MW; MacLaughlin R
    Acta Psychiatr Scand; 1992 Jul; 86(1):42-5. PubMed ID: 1414398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-lasting behavioural effects of thyrotropin-releasing hormone in depressed women: results of placebo-controlled study.
    Bunevicius R; Matulevicius V
    Psychoneuroendocrinology; 1993; 18(5-6):445-9. PubMed ID: 8416053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response studies with protirelin.
    Garbutt JC; Mayo JP; Little KY; Gillette GM; Mason GA; Dew B; Prange AJ
    Arch Gen Psychiatry; 1994 Nov; 51(11):875-83. PubMed ID: 7944876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative antidepressant effects of intravenous and intrathecal thyrotropin-releasing hormone: confounding effects of tolerance and implications for therapeutics.
    Callahan AM; Frye MA; Marangell LB; George MS; Ketter TA; L'Herrou T; Post RM
    Biol Psychiatry; 1997 Feb; 41(3):264-72. PubMed ID: 9024949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine, cardiovascular, and behavioral effects of intravenous protirelin in patients with panic disorder.
    Stein MB; Uhde TW
    Arch Gen Psychiatry; 1991 Feb; 48(2):148-56. PubMed ID: 1899183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and endocrine responses of schizophrenic patients to TRH (protirelin).
    Prange AJ; Loosen PT; Wilson IC; Meltzer HY; Fang VS
    Arch Gen Psychiatry; 1979 Sep; 36(10):1086-93. PubMed ID: 112944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRH (protirelin) in depressed alcoholic men. Behavioral changes and endocrine responses.
    Loosen PT; Prange AJ; Wilson IC
    Arch Gen Psychiatry; 1979 May; 36(5):540-7. PubMed ID: 107908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid failure and protirelin (thyrotropin-releasing hormone) test abnormalities in depressed outpatients.
    Sternbach HA; Gold MS; Pottash AC; Extein I
    JAMA; 1983 Mar; 249(12):1618-20. PubMed ID: 6402617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple hormonal responses to protirelin (TRH) in depressed patients.
    Winokur A; Amsterdam JD; Oler J; Mendels J; Snyder PJ; Caroff SN; Brunswick DJ
    Arch Gen Psychiatry; 1983 May; 40(5):525-31. PubMed ID: 6404233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protirelin (thyrotropin-releasing hormone) in amyotrophic lateral sclerosis. The role of androgens.
    Miller SC; Warnick JE
    Arch Neurol; 1989 Mar; 46(3):330-5. PubMed ID: 2563937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbamazepine increases cerebrospinal fluid thyrotropin-releasing hormone levels in affectively ill patients.
    Marangell LB; George MS; Bissette G; Pazzaglia P; Huggins T; Post RM
    Arch Gen Psychiatry; 1994 Aug; 51(8):625-8. PubMed ID: 8042911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The comparison of thyrotropin releasing hormone, luteinising hormone-releasing hormone and placebo in depressive patients using a double-blind cross-over technique.
    Benkert O; Gordon A; Martschke D
    Psychopharmacologia; 1974; 40(2):191-8. PubMed ID: 4217458
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavioral effects of protirelin in schizophrenia.
    Inanaga K; Nakano T; Nagata T; Tanaka M; Ogawa N
    Arch Gen Psychiatry; 1978 Aug; 35(8):1011-4. PubMed ID: 98128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affective state and thyrotropin and prolactin responses after repeated injections of thyrotropin-releasing hormone in depressed patients.
    Ehrensing RH; Kastin AJ; Schalch DS; Friesen HG; Vargas JR; Schally AV
    Am J Psychiatry; 1974 Jun; 131(6):714-8. PubMed ID: 4208055
    [No Abstract]   [Full Text] [Related]  

  • 16. Thyrotropin and prolactin responses to different doses of thyrotropin-releasing hormone in depression.
    Masturzo P; Tosca P; Murialdo G; Somenzini G; Cairoli S; Filippi U; De Palma D; Balbi D; Zerbi F
    Neuropsychobiology; 1989; 20(3):120-5. PubMed ID: 2503767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of endogenous depression with oral thyrotropin-releasing hormone and amitriptyline.
    Karlberg BE; Kjellman BF; Kågedal B
    Acta Psychiatr Scand; 1978 Nov; 58(5):389-400. PubMed ID: 102114
    [No Abstract]   [Full Text] [Related]  

  • 18. Biological markers of affective disorders and posttraumatic stress disorder: a pilot study with desipramine.
    Kauffman CD; Reist C; Djenderedjian A; Nelson JN; Haier RJ
    J Clin Psychiatry; 1987 Sep; 48(9):366-7. PubMed ID: 3114242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin-releasing hormone's mood-elevating effects in depressed patients, anorectic patients, and normal volunteers.
    Amsterdam J; Winokur A; Caroff S; Mendels J
    Am J Psychiatry; 1981 Jan; 138(1):115-6. PubMed ID: 6778228
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of low-dose TRH on cognitive deficits in the ECT postictal state.
    Khan A; Mirolo MH; Claypoole K; Bhang J; Cox G; Horita A; Tucker G
    Am J Psychiatry; 1994 Nov; 151(11):1694-6. PubMed ID: 7943463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.